These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7323715)

  • 1. Morphologic alterations in patients with alpha-methyldopa-induced liver damage after short- and long-term exposure.
    Arranto AJ; Sotaniemi EA
    Scand J Gastroenterol; 1981; 16(7):853-63. PubMed ID: 7323715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic follow-up of alpha-methyldopa-induced liver injury.
    Arranto AJ; Sotaniemi EA
    Scand J Gastroenterol; 1981; 16(7):865-72. PubMed ID: 7323716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of hepatic injury induced by methyldopa.
    Seggie J; Saunders SJ; Kirsch RE; Campbell JA; Gitlin N; Clain D; Terblanche J
    S Afr Med J; 1979 Jan; 55(3):75-83. PubMed ID: 424937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyldopa Hepatitis. A report of six cases and review of the literature.
    Rodman JS; Deutsch DJ; Gutman SI
    Am J Med; 1976 Jun; 60(7):941-8. PubMed ID: 937354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of methyldopa liver injury.
    Thomas E; Rosenthal WS; Zapiach L; Micci D
    Am J Gastroenterol; 1977 Aug; 68(2):125-33. PubMed ID: 920711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant hepatic failure associated with methyldopa.
    Puppala AR; Steinheber FU
    Am J Gastroenterol; 1977 Dec; 68(6):578-81. PubMed ID: 77129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyldopa liver damage.
    Toghill PJ; Smith PG; Benton P; Brown RC; Matthews HL
    Br Med J; 1974 Aug; 3(5930):545-8. PubMed ID: 4414663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage.
    Sotaniemi EA; Hokkanen OT; Ahokas JT; Pelkonen RO; Ahlqvist J
    Eur J Clin Pharmacol; 1977 Dec; 12(6):429-35. PubMed ID: 598417
    [No Abstract]   [Full Text] [Related]  

  • 9. Methyldopa-induced liver injury. Rapid progression to fatal postnecrotic cirrhosis.
    Thomas E; Bhuta S; Rosenthal WS
    Arch Pathol Lab Med; 1976 Mar; 100(3):132-5. PubMed ID: 946400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hepatitis from methyldopa.
    Maddrey WC; Boitnott JK
    Gastroenterology; 1975 Feb; 68(2):351-60. PubMed ID: 22550758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute submassive hepatic necrosis due to methyldopa. A case demonstrating possible initiation of chronic liver disease.
    Schweitzer IL; Peters RL
    Gastroenterology; 1974 Jun; 66(6):1203-11. PubMed ID: 4133500
    [No Abstract]   [Full Text] [Related]  

  • 12. Methyldopa hepatitis. Report of three cases.
    Hoyumpa AM; Connell AM
    Am J Dig Dis; 1973 Mar; 18(3):213-22. PubMed ID: 4688573
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic aggressive hepatitis after methyldopa treatment. Case report with electron-microscopic study.
    Balázs M; Kovách G
    Hepatogastroenterology; 1981 Aug; 28(4):199-202. PubMed ID: 7274982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyldopa-induced submassive hepatic necrosis.
    Rehman OU; Keith TA; Gall EA
    JAMA; 1973 Jun; 224(10):1390-2. PubMed ID: 4739987
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced active chronic hepatitis.
    Goldstein GB; Lam KC; Mistilis SP
    Am J Dig Dis; 1973 Mar; 18(3):177-84. PubMed ID: 4688569
    [No Abstract]   [Full Text] [Related]  

  • 16. [The problems of adverse effects to the liver of alpha-methyldopa].
    Zenos A
    Z Gesamte Inn Med; 1977 Apr; 32(7):168-71. PubMed ID: 17957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report. Immunological studies in a case of hepatitis following methyldopa administration.
    Delpre G; Grinblat J; Kadish U; Livni E; Shohat B; Lewitus Z; Joshua H
    Am J Med Sci; 1979; 277(2):207-13. PubMed ID: 37733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis and hemolytic anemia associated with methyldopa therapy.
    Breland BD; Hicks GS
    Drug Intell Clin Pharm; 1982 Jun; 16(6):489-92. PubMed ID: 7094845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Liver damage in patients taking methyldopa.
    Toghill PJ; Smith PG; Benton P; Brown RC; Matthews HL
    Gut; 1974 Apr; 15(4):342-3. PubMed ID: 4834576
    [No Abstract]   [Full Text] [Related]  

  • 20. Alpha-methyldopa hepatotoxicity in pregnancy.
    Ali T; Srinivasan N; Le V; Rizvi S
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):125-6. PubMed ID: 19208320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.